Dr. George Dangas On the Importance of Assessing Thrombotic Risk in Patients Undergoing PCI
By Rob Dillard, Dr. George Dangas - Last Updated: May 19, 2023Risk assessment before percutaneous coronary intervention (PCI) provides valuable information for patient management. In an exclusive interview, DocWire News spoke with Dr. George D. Dangas, about a study he led which analyzed the predictive value of the thrombotic risk criteria proposed in the 2020 ESC guidelines for non-ST-elevated acute coronary syndrome. The results were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions.
Advertisement
Advertisement
Related Posts
Ticagrelor monotherapy is linked with similar rates of recurrent coronary revascularization compared with standard therapy.
Dr. Tanvir K. Bajwa talks about the FX TAVR system, designed to improve ease of use in coronary access.
Pulmonary embolism patients treated with mechanical thrombectomy have improved outcomes and quality of life.
Marijuana users incur more than three times the risk of developing peripheral artery disease.
The novel Supira 10F system is a safe and effective percutaneous ventricular assist device for high-risk PCI.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.